Henry Ford Health System

Henry Ford Health System was paid $334.91M by Medicaid between Jan 2018 and Dec 2024, across 1030 billing codes. Its largest line is 99285, emergency room visit (most serious) — 19% of everything it billed.

33Billing provider infoHENRY FORD HEALTH SYSTEM
DETROIT, MI 48202

33aNPI1134144801assigned 07/13/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$334.91M

24GClaims9,624,453

24DCodes billed1030

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#1 of 86

Median peer was paid$21.55M

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,326,922	$47.14M
2019	1,318,823	$43.40M
2020	1,159,228	$36.68M
2021	1,469,204	$48.02M
2022	1,521,916	$52.70M
2023	1,540,504	$56.14M
2024incomplete	1,287,856	$50.82M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	19%	203,076	185,738	$62.05M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	13%	986,870	805,775	$42.11M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.7%	129,709	122,870	$22.36M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.1%	173,753	164,725	$20.40M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	3.7%	121,610	113,173	$12.28M
J9271	Injection, pembrolizumab, 1 mg	2.1%	1,279	1,006	$6.88M
96361	Intravenous infusion, hydration; each additional hour	1.9%	129,224	109,944	$6.49M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.7%	76,349	74,300	$5.79M
G0378	Hospital observation service, per hour	1.6%	20,588	19,000	$5.45M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.4%	46,208	40,411	$4.56M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	1.3%	4,811	4,414	$4.33M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.2%	30,614	29,964	$3.99M

1018 more codes

96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.0%	33,388	$3.51M
71046	Radiologic examination, chest; 2 views	<1%	85,804	$3.29M
96375	Therapeutic injection; each additional sequential IV push	<1%	100,309	$3.16M
G0451	Development testing, with interpretation and report, per standardized instrument form	<1%	63,325	$3.10M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	44,220	$2.95M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	40,597	$2.95M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	17,106	$2.85M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	39,363	$2.53M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	7,741	$2.43M
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	104,990	$2.41M
70450	Computed tomography, head or brain; without contrast material	<1%	24,900	$2.36M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	4,341	$2.19M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	98,238	$1.92M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,981	$1.91M
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	27,338	$1.80M
59025	Fetal non-stress test	<1%	21,012	$1.74M
J7300	Intrauterine copper contraceptive (paragard)	<1%	1,814	$1.71M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	6,197	$1.53M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	3,488	$1.43M
Q3014	Telehealth originating site facility fee	<1%	81,770	$1.43M
90834	Psychotherapy session, about 45 minutes	<1%	23,418	$1.36M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	22,834	$1.34M
90670		<1%	33,619	$1.34M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	27,452	$1.30M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	11,496	$1.28M
71045	Radiologic examination, chest; single view	<1%	32,426	$1.27M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	119,528	$1.25M
90677		<1%	7,949	$1.20M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	115,642	$1.18M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,606	$1.18M
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	17,440	$1.17M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	3,551	$1.16M
76830	Ultrasound, transvaginal	<1%	19,338	$1.12M
90651		<1%	15,682	$1.12M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	332	$1.10M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	47,106	$1.08M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,140	$1.08M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,239	$1.08M
20610		<1%	8,228	$1.06M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,062	$1.05M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	19,975	$1.05M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	8,532	$1.04M
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	15,245	$1.04M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	104,478	$1.02M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	22,164	$988K
70496		<1%	5,517	$916K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	23,880	$911K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	13,342	$904K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	3,603	$889K
47562		<1%	223	$889K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	45,819	$887K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	17,527	$881K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	418	$878K
93975		<1%	7,457	$853K
49083		<1%	1,762	$796K
77386		<1%	2,638	$778K
90837	Psychotherapy session, about an hour	<1%	13,955	$761K
80061	Lipid panel	<1%	65,093	$725K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	50,101	$699K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	11,703	$686K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	27,414	$672K
76801		<1%	11,613	$664K
86900		<1%	47,959	$651K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	462	$645K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	10,598	$628K
71275	Computed tomographic angiography, chest, with contrast material	<1%	7,317	$615K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	1,515	$614K
90750		<1%	4,007	$595K
97161		<1%	11,115	$577K
64635		<1%	659	$559K
67028	Intravitreal injection of a pharmacologic agent	<1%	3,112	$545K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	8,918	$543K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,567	$541K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	801	$540K
90791	Psychiatric diagnostic evaluation	<1%	8,582	$539K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	12,820	$523K
J0178	Injection, aflibercept, 1 mg	<1%	571	$509K
64493		<1%	969	$500K
62323		<1%	1,620	$489K
10060		<1%	5,012	$466K
95811		<1%	931	$457K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	6,977	$437K
43235		<1%	1,078	$408K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	4,236	$393K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	434	$393K
19083		<1%	475	$390K
99385		<1%	6,043	$389K
86780		<1%	45,362	$385K
92587		<1%	2,725	$383K
96127		<1%	34,129	$383K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	3,189	$382K
70491		<1%	3,301	$382K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	3,102	$380K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,599	$379K
72141		<1%	2,819	$378K
Q0111	Wet mounts, including preparations of vaginal, cervical or skin specimens	<1%	41,113	$366K
17110		<1%	8,258	$336K
96367		<1%	9,745	$330K
77334		<1%	771	$320K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	270	$316K
90739		<1%	1,967	$315K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	7,100	$307K
31575		<1%	3,473	$306K
74183		<1%	1,763	$304K
80053	Comprehensive metabolic panel	<1%	161,393	$301K
90832	Psychotherapy session, about 30 minutes	<1%	7,361	$301K
31231		<1%	3,349	$299K
G0008	Administration of influenza virus vaccine	<1%	28,715	$289K
77412		<1%	2,112	$288K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	8,328	$282K
90732		<1%	2,793	$277K
93971		<1%	5,089	$277K
67228		<1%	1,062	$277K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	28,483	$276K
72197		<1%	1,071	$270K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,971	$270K
97162		<1%	5,176	$261K
36430		<1%	1,652	$259K
76770		<1%	4,431	$255K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	858	$253K
84443	Thyroid stimulating hormone (TSH)	<1%	67,775	$251K
93970		<1%	2,391	$250K
90682		<1%	4,294	$250K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	90,544	$249K
96415		<1%	4,953	$248K
58301		<1%	2,117	$245K
52000		<1%	927	$238K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	340,346	$231K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,240	$231K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	79,264	$229K
99383		<1%	3,453	$227K
C8928	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report	<1%	850	$227K
20550		<1%	1,834	$226K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	14,881	$226K
77336		<1%	3,200	$221K
80048	Basic metabolic panel (calcium, ionized)	<1%	240,136	$220K
90688		<1%	18,035	$217K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	13,443	$216K
72156		<1%	1,675	$214K
99386		<1%	3,305	$210K
71250		<1%	3,758	$209K
90792	Psychiatric diagnostic evaluation with medical services	<1%	4,796	$209K
64450		<1%	876	$209K
20553		<1%	1,550	$203K
J1750	Injection, iron dextran, 50 mg	<1%	3,502	$201K
76881		<1%	3,775	$200K
92523		<1%	1,774	$199K
91320		<1%	1,875	$198K
31579		<1%	1,006	$198K
0001A		<1%	5,577	$197K
77066	Tomosynthesis, mammo	<1%	3,209	$191K
0002A		<1%	5,016	$191K
76642		<1%	5,351	$188K
11900		<1%	5,228	$188K
11104		<1%	1,180	$187K
J9022	Injection, atezolizumab, 10 mg	<1%	51	$187K
83036	Hemoglobin; glycosylated (A1C)	<1%	85,130	$185K
20611		<1%	1,645	$182K
77065	Tomosynthesis, mammo	<1%	3,812	$173K
64615		<1%	1,500	$169K
94060		<1%	1,211	$168K
95910		<1%	1,197	$167K
93797		<1%	2,501	$165K
74170		<1%	1,801	$164K
96417		<1%	3,781	$160K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	95	$156K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	10,250	$155K
76819	Fetal biophysical profile; without non-stress testing	<1%	2,414	$154K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	2,788	$153K
72125	Computed tomography, cervical spine; without contrast material	<1%	9,520	$152K
92235		<1%	1,143	$149K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	22,392	$149K
76536		<1%	2,962	$148K
86832		<1%	1,599	$144K
86833		<1%	1,576	$143K
90716		<1%	10,668	$142K
97165		<1%	2,901	$136K
72158		<1%	1,086	$136K
99382		<1%	2,094	$135K
77063	Screening digital breast tomosynthesis, bilateral	<1%	9,991	$132K
99384		<1%	2,015	$131K
86870		<1%	1,006	$130K
77300		<1%	490	$129K
70486		<1%	4,767	$129K
72131		<1%	3,749	$127K
92083		<1%	5,082	$124K
91200		<1%	2,042	$124K
90686		<1%	24,997	$122K
93798		<1%	1,918	$121K
95909		<1%	884	$121K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	9,758	$120K
70487		<1%	1,314	$112K
95911		<1%	428	$112K
71270		<1%	987	$111K
J0185	Injection, aprepitant, 1 mg	<1%	942	$110K
72100		<1%	11,151	$109K
85027		<1%	101,925	$109K
74174		<1%	645	$109K
99487	Ccm add 20min	<1%	1,759	$107K
44970		<1%	28	$107K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	129,121	$104K
80074		<1%	12,223	$104K
92651		<1%	1,019	$102K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	26,200	$101K
90734		<1%	10,738	$101K
90472	Immunization administration, each additional vaccine (list separately)	<1%	8,493	$100K
96160		<1%	6,349	$98K
87505		<1%	2,505	$96K
29075		<1%	810	$95K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	3,554	$95K
11102		<1%	997	$94K
76882		<1%	3,053	$94K
17250		<1%	1,399	$92K
99381		<1%	1,500	$92K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	1,541	$92K
90480		<1%	2,823	$91K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	22,131	$90K
90620		<1%	3,189	$90K
84702		<1%	60,355	$89K
86480		<1%	6,576	$89K
94010		<1%	7,756	$87K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	1,623	$85K
76825		<1%	289	$84K
J9299	Injection, nivolumab, 1 mg	<1%	18	$84K
73700		<1%	1,743	$84K
36591		<1%	3,388	$84K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	8,195	$83K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	47,753	$82K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	340	$82K
90678		<1%	277	$82K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,752	$81K
93308		<1%	832	$81K
82728		<1%	27,311	$79K
94726		<1%	1,143	$79K
95117		<1%	3,780	$79K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	6,659	$76K
Q0222	Injection, bebtelovimab, 175 mg	<1%	187	$76K
11100		<1%	495	$75K
99406		<1%	4,881	$75K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	240	$72K
87808		<1%	50,913	$72K
86803		<1%	43,500	$72K
77080		<1%	1,176	$71K
83970		<1%	6,855	$71K
J7323	Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose	<1%	655	$71K
J2327	Injection, risankizumab-rzaa, intravenous, 1 mg	<1%	13	$69K
73221		<1%	653	$69K
92586		<1%	966	$68K
G0009	Administration of pneumococcal vaccine	<1%	7,075	$68K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	5,401	$66K
92550		<1%	4,707	$65K
73562		<1%	22,408	$65K
0124A		<1%	2,008	$63K
85610		<1%	113,549	$62K
58100		<1%	676	$61K
62270		<1%	227	$61K
0054A		<1%	1,632	$59K
82607		<1%	21,625	$58K
83550		<1%	29,465	$58K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,265	$58K
92557		<1%	7,872	$58K
87536		<1%	6,146	$57K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	5,499	$57K
58300		<1%	3,226	$56K
71271		<1%	901	$55K
81373		<1%	799	$55K
97535	Self-care/home management training, each 15 minutes	<1%	1,783	$53K
82947		<1%	19,078	$52K
83655		<1%	18,900	$52K
72128		<1%	1,410	$52K
P9046	Infusion, albumin (human), 25%, 20 ml	<1%	553	$52K
83013		<1%	2,616	$51K
97166		<1%	1,057	$51K
83735		<1%	171,157	$51K
96411		<1%	1,374	$51K
86003		<1%	4,880	$50K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	22,766	$49K
11056		<1%	1,267	$49K
73030		<1%	15,505	$49K
20600		<1%	386	$48K
73630		<1%	22,756	$47K
93296		<1%	2,487	$47K
J1729	Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg	<1%	588	$46K
43264		<1%	107	$46K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	2,612	$46K
0071A		<1%	1,169	$45K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,174	$44K
83540		<1%	30,253	$44K
73130		<1%	18,405	$42K
87522	Neg quan hep c or qual rna	<1%	4,088	$42K
87086	Culture, bacterial; quantitative colony count, urine	<1%	58,528	$42K
29515		<1%	550	$41K
73610		<1%	17,939	$41K
96161		<1%	2,682	$41K
10061		<1%	239	$41K
82746		<1%	14,710	$41K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	18,847	$41K
86235		<1%	4,653	$40K
93017		<1%	3,143	$40K
96132		<1%	450	$40K
80197		<1%	8,584	$40K
97116		<1%	3,473	$40K
J1726	Injection, hydroxyprogesterone caproate, (makena), 10 mg	<1%	195	$40K
84403		<1%	5,176	$39K
72050		<1%	2,956	$39K
98941	Chiropractic manipulative treatment; spinal, 3-4 regions	<1%	4,533	$39K
74178		<1%	231	$39K
69210		<1%	3,419	$38K
82105		<1%	10,675	$37K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	186	$37K
93976		<1%	696	$37K
84439		<1%	16,232	$37K
95908		<1%	280	$36K
96416		<1%	209	$36K
20526		<1%	280	$36K
96402		<1%	1,590	$35K
87497		<1%	3,206	$35K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	24,964	$35K
0004A		<1%	953	$35K
36561		<1%	27	$35K
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	801	$35K
0072A		<1%	886	$34K
G0010	Administration of hepatitis b vaccine	<1%	2,252	$34K
92250		<1%	8,455	$34K
90656		<1%	2,978	$33K
82570		<1%	28,023	$33K
82248		<1%	90,983	$32K
86580		<1%	3,989	$32K
87340		<1%	23,752	$31K
12032		<1%	242	$31K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	76	$31K
19318		<1%	14	$31K
81370		<1%	153	$31K
83880		<1%	36,114	$31K
92552		<1%	1,447	$31K
90658		<1%	3,414	$31K
95250		<1%	486	$28K
92579		<1%	1,922	$28K
91010		<1%	135	$28K
81025		<1%	124,396	$28K
88342		<1%	8,895	$27K
82043		<1%	21,179	$27K
36415	Collection of venous blood by venipuncture	<1%	25,173	$27K
93922		<1%	1,343	$26K
81376		<1%	206	$26K
82784		<1%	6,893	$26K
74018		<1%	5,275	$25K
86923		<1%	1,921	$25K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	2,047	$25K
95713		<1%	83	$25K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,393	$25K
80076		<1%	14,852	$25K
82670		<1%	3,661	$25K
0052A		<1%	651	$25K
92136		<1%	1,358	$24K
90461		<1%	59,307	$24K
86762		<1%	15,668	$23K
73502		<1%	7,890	$23K
0051A		<1%	617	$23K
11721		<1%	3,203	$23K
72070		<1%	1,615	$23K
84146		<1%	4,398	$22K
86360		<1%	5,444	$22K
81001		<1%	149,918	$22K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	<1%	21	$22K
86160		<1%	6,179	$22K
20605		<1%	183	$22K
66982		<1%	27	$22K
70544		<1%	477	$21K
82951		<1%	2,717	$21K
73110		<1%	10,881	$21K
77301		<1%	30	$21K
17111		<1%	430	$21K
86147		<1%	1,659	$21K
72157		<1%	206	$20K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	16,890	$20K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	77	$20K
93350		<1%	109	$20K
83001		<1%	4,542	$20K
96118		<1%	349	$20K
95700		<1%	163	$19K
0081A		<1%	494	$19K
95951		<1%	81	$19K
72146		<1%	149	$18K
86593		<1%	3,188	$18K
99215	Doctor's office visit, returning patient (complex)	<1%	278	$18K
83993		<1%	2,099	$18K
94618		<1%	1,508	$18K
G0390	Trauma response team associated with hospital critical care service	<1%	40	$18K
86592		<1%	5,115	$18K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,180	$18K
86140		<1%	22,488	$18K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	65	$18K
72040		<1%	2,803	$17K
87517		<1%	1,630	$17K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	138	$17K
88184		<1%	283	$17K
70543		<1%	61	$17K
10005		<1%	52	$17K
99213	Doctor's office visit, returning patient (routine)	<1%	587	$17K
87081		<1%	46,601	$17K
10120		<1%	89	$16K
11055		<1%	557	$16K
70498		<1%	5,095	$16K
84460		<1%	40,701	$16K
82565		<1%	9,633	$16K
90662		<1%	830	$16K
85730		<1%	84,335	$15K
95800		<1%	189	$15K
84450		<1%	9,594	$15K
86706		<1%	8,073	$15K
95913		<1%	53	$15K
74022		<1%	10,136	$15K
84425		<1%	2,329	$14K
82465		<1%	5,847	$14K
92134		<1%	10,726	$14K
73560		<1%	3,063	$14K
99204	Doctor's office visit, new patient (more involved)	<1%	209	$14K
77338		<1%	79	$14K
64483		<1%	38	$14K
87529		<1%	3,103	$14K
86769		<1%	635	$14K
73521		<1%	1,433	$14K
82677		<1%	2,378	$13K
83516		<1%	3,511	$13K
0082A		<1%	342	$13K
99495		<1%	208	$13K
85007		<1%	25,235	$13K
84100		<1%	41,603	$13K
41828		<1%	12	$13K
11981		<1%	253	$12K
82247		<1%	34,984	$12K
86255		<1%	6,290	$12K
70480		<1%	182	$12K
83002		<1%	3,011	$12K
G2214	Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional	<1%	268	$12K
11750		<1%	65	$12K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	18	$12K
83721		<1%	5,235	$12K
64405		<1%	95	$12K
97014		<1%	1,517	$12K
86704		<1%	5,853	$11K
20680		<1%	17	$11K
78264		<1%	53	$11K
43244		<1%	12	$11K
93750		<1%	242	$11K
83615		<1%	12,235	$11K
84481		<1%	2,258	$11K
88341		<1%	2,282	$11K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	261	$11K
97012		<1%	1,555	$10K
73080		<1%	6,031	$10K
51798		<1%	7,116	$10K
77290		<1%	65	$10K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	356	$10K
81003		<1%	67,772	$10K
72110		<1%	880	$10K
86039		<1%	6,719	$10K
73564		<1%	1,482	$10K
87799		<1%	877	$10K
84153		<1%	2,160	$10K
87902		<1%	409	$10K
99232	Hospital visit by a doctor, follow-up day	<1%	227	$10K
96130		<1%	577	$10K
83020		<1%	10,399	$9K
87186		<1%	12,926	$9K
G0379	Direct admission of patient for hospital observation care	<1%	29	$9K
92551		<1%	1,116	$9K
74019		<1%	1,563	$9K
12041		<1%	54	$9K
73590		<1%	7,441	$9K
87210		<1%	22,660	$9K
73552		<1%	3,655	$9K
86336		<1%	2,459	$9K
82627		<1%	1,394	$9K
92133		<1%	6,566	$9K
43259		<1%	24	$9K
57454		<1%	66	$9K
84165		<1%	4,664	$9K
87430		<1%	19,248	$8K
96380		<1%	454	$8K
73140		<1%	4,489	$8K
87631		<1%	4,040	$8K
86376		<1%	2,909	$8K
72082		<1%	258	$8K
85652		<1%	19,704	$8K
11982		<1%	61	$8K
96138		<1%	694	$8K
0031A		<1%	224	$8K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	35,547	$8K
87077		<1%	10,485	$8K
0154A		<1%	209	$8K
99203	Doctor's office visit, new patient (routine)	<1%	191	$8K
29540		<1%	108	$8K
80069		<1%	4,517	$8K
73200		<1%	156	$7K
95816		<1%	69	$7K
82533		<1%	1,457	$7K
97035		<1%	1,199	$7K
86696		<1%	2,287	$7K
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	114	$7K
72170		<1%	2,211	$7K
92002		<1%	120	$7K
84445		<1%	555	$7K
82550		<1%	11,916	$7K
96523		<1%	270	$7K
29105		<1%	88	$6K
C1769	Guide wire	<1%	4,941	$6K
82274		<1%	733	$6K
86200		<1%	4,463	$6K
84156		<1%	8,724	$6K
73100		<1%	835	$6K
87324		<1%	1,538	$6K
82378		<1%	2,014	$6K
84144		<1%	1,255	$6K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	82	$6K
C9257	Injection, bevacizumab, 0.25 mg	<1%	1,469	$6K
84520		<1%	4,129	$6K
73090		<1%	5,367	$6K
88307		<1%	1,163	$6K
84550		<1%	6,518	$6K
86787		<1%	3,253	$6K
36600		<1%	1,849	$6K
82952		<1%	2,599	$6K
72072		<1%	879	$5K
Q2036	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)	<1%	703	$5K
87634		<1%	6,275	$5K
97022		<1%	807	$5K
84478		<1%	115	$5K
86850		<1%	46,086	$5K
12051		<1%	29	$5K
86708		<1%	3,037	$5K
86695		<1%	2,288	$5K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	812	$5K
86334		<1%	1,169	$5K
0012A		<1%	126	$5K
0121A		<1%	184	$5K
74160		<1%	75	$5K
99205	Prolong outpt/office vis	<1%	50	$5K
82330		<1%	4,884	$5K
86665		<1%	1,458	$5K
92025		<1%	1,343	$4K
0074A		<1%	167	$4K
0011A		<1%	134	$4K
36592		<1%	292	$4K
86146		<1%	1,397	$4K
86901		<1%	47,822	$4K
71101		<1%	943	$4K
86828		<1%	481	$4K
84484		<1%	73,517	$4K
83690		<1%	67,220	$4K
86431		<1%	5,879	$4K
83014		<1%	1,692	$4K
30140		<1%	12	$4K
82962		<1%	75,659	$4K
73060		<1%	3,018	$4K
69209		<1%	582	$4K
86301		<1%	1,243	$4K
82024		<1%	296	$4K
90675		<1%	23	$4K
64447		<1%	158	$4K
92060		<1%	884	$4K
87329		<1%	819	$4K
74220		<1%	52	$3K
0003A		<1%	112	$3K
84207		<1%	523	$3K
64415		<1%	139	$3K
67210		<1%	16	$3K
99496		<1%	50	$3K
76831		<1%	41	$3K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	96	$3K
87088		<1%	5,288	$3K
95912		<1%	12	$3K
0173A		<1%	80	$3K
97168		<1%	92	$3K
90744		<1%	646	$3K
85018		<1%	6,218	$3K
0151A		<1%	94	$3K
87070		<1%	7,940	$3K
0083A		<1%	83	$3K
88173		<1%	800	$3K
93298		<1%	167	$3K
86765		<1%	1,209	$3K
73000		<1%	879	$3K
71100		<1%	1,908	$3K
96401		<1%	224	$3K
90723		<1%	30,255	$3K
83525		<1%	682	$3K
76857		<1%	67	$3K
85014		<1%	5,704	$3K
84480		<1%	609	$3K
29125		<1%	2,639	$3K
76820		<1%	4,617	$3K
86304		<1%	536	$3K
88112		<1%	913	$3K
86705		<1%	1,635	$3K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	22	$3K
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	32	$3K
76813		<1%	129	$3K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,244	$3K
72193		<1%	32	$3K
97163		<1%	64	$3K
73501		<1%	443	$3K
72202		<1%	244	$3K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	740	$3K
92020		<1%	1,321	$3K
46600		<1%	707	$3K
87338		<1%	546	$3K
88360		<1%	183	$3K
97164		<1%	70	$3K
00731		<1%	67	$3K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	12	$3K
86036		<1%	792	$3K
90746		<1%	37	$2K
80164		<1%	1,602	$2K
83921		<1%	711	$2K
87205		<1%	8,301	$2K
85045		<1%	4,159	$2K
78306		<1%	13	$2K
88312		<1%	741	$2K
99492		<1%	48	$2K
83520		<1%	588	$2K
85613		<1%	1,169	$2K
82803		<1%	27,571	$2K
88304		<1%	2,585	$2K
82085		<1%	1,683	$2K
90681		<1%	15,054	$2K
70355		<1%	292	$2K
86694		<1%	708	$2K
51701		<1%	969	$2K
12001		<1%	3,742	$2K
73660		<1%	1,014	$2K
87147		<1%	5,150	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	49	$2K
92285		<1%	977	$2K
83010		<1%	1,328	$2K
51725		<1%	13	$2K
73620		<1%	615	$2K
82088		<1%	155	$2K
82103		<1%	1,304	$2K
M0239	Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring	<1%	13	$2K
0171A		<1%	62	$2K
82390		<1%	1,292	$2K
92567		<1%	6,360	$2K
86664		<1%	1,448	$2K
84132		<1%	6,135	$2K
86300		<1%	305	$2K
82010		<1%	9,546	$2K
57456		<1%	14	$2K
86038		<1%	975	$2K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	1,161	$2K
89060		<1%	1,841	$2K
82150		<1%	4,844	$2K
12031		<1%	12	$2K
82164		<1%	989	$2K
95806		<1%	25	$2K
29405		<1%	15	$2K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	31	$2K
20552		<1%	13	$2K
64400		<1%	12	$2K
84630		<1%	596	$2K
99223	Prolong inpt eval add15 m	<1%	14	$2K
12011		<1%	2,508	$2K
87420		<1%	4,789	$2K
11200		<1%	77	$2K
86381		<1%	375	$2K
72195		<1%	13	$2K
87101		<1%	2,296	$2K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	288	$2K
85379		<1%	20,802	$2K
C1729	Catheter, drainage	<1%	2,210	$2K
C1726	Catheter, balloon dilatation, non-vascular	<1%	692	$2K
85660		<1%	817	$1K
87040		<1%	9,597	$1K
96119		<1%	163	$1K
72080		<1%	107	$1K
99217		<1%	32	$1K
99464		<1%	31	$1K
85732		<1%	1,087	$1K
85384		<1%	1,115	$1K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	34	$1K
74230		<1%	26	$1K
C1889	Implantable/insertable device, not otherwise classified	<1%	122	$1K
87209		<1%	693	$1K
11720		<1%	202	$1K
80177		<1%	3,001	$1K
83605		<1%	37,020	$1K
84134		<1%	208	$1K
82525		<1%	494	$1K
90715		<1%	19,621	$1K
83498		<1%	345	$1K
86644		<1%	1,188	$1K
95819		<1%	14	$1K
90647		<1%	29,971	$1K
82140		<1%	1,779	$1K
92611		<1%	26	$1K
76821		<1%	1,566	$1K
86225		<1%	750	$1K
17000		<1%	133	$1K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	26	$1K
73070		<1%	394	$1K
90380		<1%	207	$1K
70481		<1%	12	$1K
51702		<1%	94	$1K
84244		<1%	157	$1K
99401		<1%	27	$1K
84300		<1%	1,312	$987.73
70360		<1%	748	$980.08
0172A		<1%	26	$965.13
64445		<1%	28	$957.25
88261		<1%	16	$952.61
88313		<1%	613	$946.23
00142		<1%	23	$893.68
97803		<1%	273	$887.83
83090		<1%	208	$864.09
90685		<1%	3,062	$846.62
88185		<1%	191	$834.38
86735		<1%	302	$823.07
76942		<1%	768	$814.66
87102		<1%	1,341	$802.29
84075		<1%	27,972	$792.64
86015		<1%	380	$779.82
69200		<1%	142	$775.90
82785		<1%	408	$758.06
81513		<1%	26	$748.57
84163		<1%	693	$723.24
87563		<1%	132	$721.64
77072		<1%	26	$718.64
99152		<1%	6,217	$708.79
86141		<1%	228	$701.44
73120		<1%	55	$671.82
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	29	$665.43
88108		<1%	396	$662.37
89051		<1%	3,405	$660.09
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,889	$653.10
95886		<1%	4,377	$633.11
87177		<1%	678	$625.02
00811		<1%	18	$617.13
99238	Hospital discharge day management, 30 minutes or less	<1%	14	$613.50
94729		<1%	4,800	$612.28
76512		<1%	129	$587.26
0064A		<1%	16	$580.50
87901		<1%	25	$578.68
76870		<1%	2,634	$571.65
84681		<1%	118	$551.06
93926		<1%	12	$527.04
96368		<1%	3,982	$523.40
84145		<1%	1,570	$480.24
87255		<1%	279	$478.44
J2358	Injection, olanzapine, long-acting, 1 mg	<1%	68	$477.48
98940		<1%	64	$462.53
92226		<1%	287	$453.20
82977		<1%	225	$442.45
90846	Family psychotherapy without the patient present, 50 minutes	<1%	13	$441.34
11901		<1%	12	$437.74
92082		<1%	58	$434.36
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	87	$431.30
96101		<1%	76	$431.16
92610		<1%	12	$427.78
0053A		<1%	12	$402.30
12013		<1%	132	$399.14
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	27	$384.16
86645		<1%	262	$365.70
86308		<1%	3,159	$357.17
73600		<1%	282	$355.31
93225		<1%	12	$349.86
84295		<1%	430	$344.79
93320		<1%	2,271	$343.54
12002		<1%	2,009	$336.20
87015		<1%	157	$329.55
64494		<1%	862	$321.05
83930		<1%	2,202	$320.89
87075		<1%	1,128	$310.00
96136		<1%	449	$303.88
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	<1%	166	$302.92
76519		<1%	13	$293.86
85240		<1%	101	$292.78
87906		<1%	25	$289.36
72220		<1%	96	$281.47
86618		<1%	117	$277.18
82077		<1%	8,360	$272.26
80158		<1%	47	$258.01
Q0112	All potassium hydroxide (koh) preparations	<1%	68	$249.86
73650		<1%	177	$247.80
64636		<1%	661	$236.49
72190		<1%	14	$229.20
96120		<1%	80	$220.46
96102		<1%	142	$220.46
87593		<1%	32	$217.16
84466		<1%	63	$213.85
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	12	$209.96
96376		<1%	29,157	$206.69
74420		<1%	53	$205.58
85246		<1%	55	$202.32
11730		<1%	25	$196.29
84080		<1%	54	$194.80
99407		<1%	12	$191.96
99417	Prolong home eval add 15m	<1%	564	$185.60
Q2038	Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)	<1%	18	$180.60
G0168	Wound closure utilizing tissue adhesive(s) only	<1%	14	$178.28
76937		<1%	882	$174.09
83718		<1%	51	$168.71
85245		<1%	43	$156.36
86777		<1%	92	$156.11
80185		<1%	620	$152.28
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,241	$150.81
76376		<1%	1,598	$146.50
84432		<1%	28	$145.46
80143		<1%	2,189	$141.96
85651		<1%	383	$138.82
90714		<1%	1,529	$129.60
76827		<1%	284	$121.88
88280		<1%	16	$120.64
80179		<1%	2,000	$120.31
86008		<1%	24	$120.06
77073		<1%	28	$118.56
36416		<1%	2,570	$111.36
76514		<1%	2,327	$110.23
86355		<1%	12	$104.85
80178		<1%	52	$104.32
85049		<1%	64	$103.92
82955		<1%	104	$103.41
88285		<1%	16	$97.00
82542		<1%	31	$96.74
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	4,031	$90.00
J2305	Injection, nitroglycerin, 5 mg	<1%	42	$83.21
86318		<1%	99	$79.62
85347		<1%	99	$79.40
G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	<1%	83	$78.24
80202		<1%	21	$76.91
93325		<1%	2,655	$74.75
83935		<1%	158	$73.61
88142		<1%	12	$73.04
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	28,193	$72.85
91318		<1%	297	$72.33
86340		<1%	13	$68.64
77002		<1%	1,801	$67.84
84166		<1%	13	$65.06
J1836	Injection, metronidazole, 10 mg	<1%	485	$58.85
J3490	Unclassified drugs	<1%	14,275	$58.67
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	<1%	1,021	$57.37
77001		<1%	331	$56.70
82787		<1%	13	$53.70
84590		<1%	12	$52.88
99153	Mod sedat endo service >5yrs	<1%	4,066	$52.54
84133		<1%	83	$50.00
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	610	$48.66
81002		<1%	244	$47.75
86256		<1%	27	$45.17
87046		<1%	16	$43.10
87045		<1%	16	$43.10
80175		<1%	31	$39.50
90687		<1%	392	$38.33
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	252	$37.55
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	6,599	$32.40
82652		<1%	12	$30.49
82985		<1%	12	$30.03
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	95	$28.28
90713		<1%	1,530	$28.14
29130		<1%	49	$27.98
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	16,397	$26.84
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	14,007	$25.57
85307		<1%	12	$25.14
86778		<1%	27	$25.06
82310		<1%	13	$22.10
J2704	Injection, propofol, 10 mg	<1%	8,685	$22.05
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,870	$21.77
90633		<1%	21,210	$21.00
82945		<1%	373	$17.84
84157		<1%	399	$17.68
80165		<1%	13	$16.76
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,179	$15.52
90710		<1%	9,051	$14.00
87449		<1%	14	$13.01
88311		<1%	42	$12.99
94760		<1%	128	$12.19
82042		<1%	60	$11.35
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	2,568	$11.20
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	77	$10.94
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	5,326	$10.23
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	318	$9.72
88300		<1%	12	$8.72
90696		<1%	8,871	$7.00
90700		<1%	10,370	$7.00
87116		<1%	12	$6.83
82435		<1%	122	$6.48
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	15,048	$6.40
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	67,328	$6.36
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	4,372	$6.06
J2470	Injection, pantoprazole sodium, 40 mg	<1%	449	$5.76
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	<1%	1,088	$4.93
82272		<1%	2,104	$4.86
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,638	$4.76
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	478	$3.95
82040		<1%	12	$3.01
J2060	Injection, lorazepam, 2 mg	<1%	564	$2.17
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	2,217	$2.13
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	8,365	$0.44
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,163	$0.24
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	525	$0.03
V2632	Posterior chamber intraocular lens	0%	1,741	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	319	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	731	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	555	$0.00
90632		0%	906	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	459	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	254	$0.00
91307		0%	2,237	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	559	$0.00
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	0%	81	$0.00
G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	0%	943	$0.00
A4648	Tissue marker, implantable, any type, each	0%	1,236	$0.00
95885		0%	93	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	747	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	551	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	143	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	1,114	$0.00
Q0247	Injection, sotrovimab, 500 mg	0%	71	$0.00
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	0%	402	$0.00
91305		0%	2,836	$0.00
90381		0%	336	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	250	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	16	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	57	$0.00
83883		0%	45	$0.00
96110	Developmental screening, with scoring and documentation, per standardized instrument	0%	349	$0.00
91317		0%	187	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	270	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	372	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	246	$0.00
94660		0%	77	$0.00
96139		0%	129	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	319	$0.00
91315		0%	270	$0.00
76377		0%	69	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	18	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	38	$0.00
74328		0%	57	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	33	$0.00
Q0221	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg	0%	13	$0.00
91301		0%	247	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	264	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	13	$0.00
J1815	Injection, insulin, per 5 units	0%	168	$0.00
91319		0%	194	$0.00
91303		0%	26	$0.00
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	0%	14	$0.00
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	0%	16	$0.00
91306		0%	15	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	14	$0.00
99156		0%	13	$0.00
C1758	Catheter, ureteral	0%	1,096	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	638	$0.00
90707		0%	10,920	$0.00
51741		0%	24	$0.00
58340		0%	81	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	3,046	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	118	$0.00
90836		0%	328	$0.00
92504		0%	633	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	5,419	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	1,548	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	204	$0.00
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	0%	3,288	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	538	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	3,531	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	5,330	$0.00
91312		0%	1,926	$0.00
J2800	Injection, methocarbamol, up to 10 ml	0%	382	$0.00
11101		0%	19	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	222	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	740	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	922	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	1,373	$0.00
96133		0%	409	$0.00
88302		0%	12	$0.00
C1765	Adhesion barrier	0%	723	$0.00
77012		0%	25	$0.00
91300		0%	11,520	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	91	$0.00
J1939	Injection, bumetanide, 0.5 mg	0%	13	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	238	$0.00
95874		0%	24	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	103	$0.00
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	0%	81	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	303	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	232	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	86	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	1,194	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	174	$0.00
82365		0%	25	$0.00
Q9956	Injection, octafluoropropane microspheres, per ml	0%	26	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	159	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	132	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	124	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	1,198	$0.00
91308		0%	496	$0.00
82375		0%	203	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	71	$0.00
C1874	Stent, coated/covered, with delivery system	0%	31	$0.00
93356		0%	82	$0.00
C2625	Stent, non-coronary, temporary, with delivery system	0%	42	$0.00
77003		0%	62	$0.00
93321		0%	13	$0.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	0%	542	$0.00
J1644	Injection, heparin sodium, per 1000 units	0%	111	$0.00
73565		0%	37	$0.00
17003		0%	13	$0.00
90672		0%	205	$0.00
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	0%	33	$0.00
C1776	Joint device (implantable)	0%	30	$0.00
82610		0%	27	$0.00
77062		0%	51	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	63	$0.00
86922		0%	40	$0.00
Q0239	Injection, bamlanivimab-xxxx, 700 mg	0%	12	$0.00
90655		0%	24	$0.00
Q0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAMSCHRODER, ROBIN (EVP, FIN AND BUS DEV OFFICER)

Same official

Other billing entities under DAMSCHRODER, ROBIN

Full network →

Provider	Location	Paid
Henry Ford Health ST. John Hospital	Chicago, IL	$159.41M
Henry Ford Health Providence Hospital	Novi, MI	$72.76M
Henry Ford Wyandotte Hospital	Wyandotte, MI	$60.54M
Henry Ford Health Macomb Oakland Hospital	Warren, MI	$59.25M
W.A. Foote Memorial Hospital	Jackson, MI	$41.32M
Henry Ford Macomb Hospital Corporation	Clinton Twp, MI	$40.96M
Henry Ford Health Genesys Hospital	Grand Blanc, MI	$31.39M
Henry Ford Health Macomb Oakland Hospital	Madison Heights, MI	$24.76M
Henry Ford Health System	West Bloomfield, MI	$19.27M
Henry Ford Health Rochester Hospital	Rochester, MI	$11.98M
Henry Ford Health River District Hospital	East China, MI	$4.59M
W.A. Foote Memorial Hospital	Jackson, MI	$2.11M
Henry Ford Health Providence Hospital	Novi, MI	$255K
Henry Ford Health ST. John Hospital	Detroit, MI	$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.